» Authors » Simon P Mooijaart

Simon P Mooijaart

Explore the profile of Simon P Mooijaart including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 228
Citations 5042
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Meuleman Y, Schade van Westrum E, Bos W, Mooijaart S, van Buren M, Tripepi G, et al.
Clin Kidney J . 2025 Mar; 18(3):sfae422. PMID: 40078518
Clinical and epidemiological research is indispensable for improvements in evidence-based healthcare and health outcomes, but it also leaves important gaps in our understanding of health and illness. Qualitative research has...
2.
van der Slot A, Mooijaart S, van Dalen J, Hoevenaar M, Richard E, Giltay E
Am J Geriatr Psychiatry . 2025 Mar; PMID: 40074663
Background: The prevalence of depressive symptoms, apathy, and cognitive decline increases with age. Understanding the temporal dynamics of these symptoms could provide valuable insights into the early stages of cognitive...
3.
Venema J, Kuranova A, Bizzarri D, Mooijaart S, Kerckhoffs A, Slieker K, et al.
Geroscience . 2025 Mar; PMID: 40067540
The disease course and outcome of COVID-19 greatly varies between individuals. To explore which biological systems may contribute to this variation, we examined how individual metabolites and three metabolic scores...
4.
van der Klei V, van den Bos F, Mooijaart S, Julien A, Maissan M, van Raaij B, et al.
Age Ageing . 2025 Feb; 54(2). PMID: 39976284
Background: Increasingly frailty assessment is part of the shared decision-making process of older patients. However, little is known of the role of frailty in goals of care among the diverse...
5.
Zahra A, van Smeden M, Elders P, Festen J, Gussekloo J, Joling K, et al.
BMC Geriatr . 2025 Jan; 25(1):67. PMID: 39885429
Background: During the COVID-19 pandemic, nursing home (NH) residents faced the highest risk of severe COVID-19 disease and mortality. Due to their frailty status, comorbidity burden can serve as a...
6.
van Raaij B, Zahra A, Steyerberg E, de Hond A, Smits R, van der Klei V, et al.
J Clin Epidemiol . 2024 Dec; 179():111652. PMID: 39732182
Objectives: During the COVID-19 pandemic, dynamic factors, such as governmental policies, improved treatment, prevention options, and viral mutations changed the incidence of outcomes and possibly changed the relation between predictors...
7.
Tran Van Hoi E, Santegoets S, Mooijaart S, van Heemst D, Ozkan A, Verdegaal E, et al.
Immun Ageing . 2024 Nov; 21(1):83. PMID: 39593063
Introduction: Immunotherapy with checkpoint inhibition (ICI) is increasingly prescribed to older patients with cancer. High age, especially in combination with frailty, has been associated to immune senescence, which is the...
8.
Duin J, Baltussen J, Albalak G, van Dam van Isselt E, Portielje J, Mooijaart S, et al.
Oncologist . 2024 Nov; PMID: 39566085
Background: Despite the increasing integration of wearable technology in oncology, its application in the care of older adults, representing most patients with cancer, is poorly defined. Objective: This systematic review...
9.
Luijten D, Abbel D, Cannegieter S, Eikenboom J, den Exter P, Gussekloo J, et al.
J Thromb Haemost . 2024 Oct; 23(2):588-599. PMID: 39454882
Background: Managing older patients with acute pulmonary embolism (PE) is challenging due to their underrepresentation in clinical trials, comorbidities, and increased complication risk. Objectives: To evaluate risk assessment and management...
10.
Zonneveld M, Al Kuhaili N, Mooijaart S, Slagboom P, Jukema J, Noordam R, et al.
Geroscience . 2024 Oct; PMID: 39436550
The 1-HMR metabolomics-based MetaboHealth score, comprised of 14 serum metabolic markers, associates with disease-specific mortality, but it is unclear whether the score also reflects cognitive changes and functional impairment. We...